Covid-19 Vaccines, No-vax poll, Pandemic antibiotics, Social distancing confusion, Reopening America, Metformin recalled, Brian Hooker PhD, Vax vs Un-vax study, Irish boy autism, Medical Experimentation on Children, Zoloft shortage and MORE!

Jun 2nd, 2020 3-5PM ET

Tuesday on The Robert Scott Bell Show:

Covid-19 In Kids: A Reason To Be Wary Of Covid-19 Vaccines More than a dozen Covid-19 vaccines are in development, with many of them already being tested in humans and many more to begin human trials soon. But what do we actually know about these potential vaccines and why might we be wary of them? Wary, of course, does not mean we stop testing them, but it does mean we must be careful, to fully understand what they do, what they don’t do, and what harm they might cause to otherwise healthy adults and children.First, what don’t we know?We do not know if they are safe. No human safety data is available to the public as far as I am aware, though some companies have issued press releases claiming safety without releasing the data. This is a concern as we are contemplating eventually giving vaccines to two to three billion people or more. One adverse reaction will result in many millions either injured or killed. We don’t know if they will protect anyone from infection. Yes, they raise antibodies in experimental animals but it is still unclear whether the animals are protected.Data from studies with a very limited number of non-human primates (monkeys) is available for one type of vaccine (an adenovirus vector that carries the spike protein gene of SARS-CoV-2). Vaccination failed to protect any of the monkeys from infection of the nasal but did lower the amount of virus as virus-associated damage to the lung. Similar results were found for experimental SARS and MERS vaccines. Extrapolation of the degree protection of the lung from monkey to human is difficult as SARS-CoV-2 does not cause serious disease in these animals.

27% unlikely to be vaccinated against the coronavirus; Republicans, conservatives especially: POLL Unpersuaded by more than 100,000 pandemic deaths in the United States, 45% of strong conservatives, four in 10 Republicans and nearly as many evangelical Christians say they’d be unlikely to get vaccinated against the coronavirus, even for free.Overall, 27% of adults in an ABC News/Washington Post poll say they definitely (15%) or probably (12%) would not get the vaccine. Among them, half say they don’t trust vaccines in general, while nearly a quarter don’t think it’s needed in this case.A plurality definitely would get vaccinated (43%) and 28% say they probably would. The net, 71%, is much higher than the adult vaccination rate for the standard seasonal flu – 45% in the 2018-19 flu season, according to the U.S. Centers for Disease Control and Prevention (with a wide range by state, from 34 to 56%.) It’s much lower than the 2017 child vaccination rates for polio and measles/mumps/rubella, 93 and 92%, respectively.A mix of groups express less interest in getting vaccinated – 46% of Republican women, 45% (as noted) very conservative Americans, 40% of Republicans and 37% of evangelical Christians.Across the spectrum, 90% of Democratic men say they definitely or probably would get the vaccine, as would 81% of Democrats overall, and as many liberals in this poll, produced for ABC by Langer Research Associates.Interest is higher, although not overwhelmingly high, among seniors – 77% – compared with all other adults, 69%.

Pandemic antibiotics surge will cause more deaths: WHO Increased antibiotics use in combating the COVID-19 pandemic will strengthen bacterial resistance and ultimately lead to more deaths during the crisis and beyond, the World Health Organization said Monday.WHO director-general Tedros Adhanom Ghebreyesus said a “worrying number” of bacterial infections were becoming increasingly resistant to the medicines traditionally used to treat them.The UN health agency said it was concerned that the inappropriate use of antibiotics during the coronavirus crisis would further fuel the trend.”The COVID-19 pandemic has led to an increased use of antibiotics, which ultimately will lead to higher bacterial resistance rates that will impact the burden of disease and deaths during the pandemic and beyond,” Tedros told a virtual press conference from the WHO’s Geneva headquarters.The WHO said only a small proportion of COVID-19 patients needed antibiotics to treat subsequent bacterial infections.The organisation has issued guidance to medics not to provide antibiotic therapy or prophylaxis to patients with mild COVID-19, or to patients with moderate illness without a clinical suspicion of bacterial infection.Tedros said the guidelines said should help tackle antimicrobial resistance while saving lives.He called the threat of antimicrobial resistance “one of the most urgent challenges of our time”.

6 feet of social distancing best, but even 3 feet should help: study While most public health officials recommend you put 6 feet between yourself and others, a new review of 172 studies from 16 countries concluded that keeping 3 feet apart might also protect you to some degree.And while face masks and eye protection might add even more layers of protection, these precautions aren’t 100% foolproof, the researchers added.Still, the Canadian study found that face masks, eye protection and keeping at least 3 feet away from people gives you the best chance of avoiding infection.”Our findings are the first to synthesize all direct information on COVID-19, SARS and MERS, and provide the currently best available evidence on the optimum use of these common and simple interventions to help ‘flatten the curve’ and inform pandemic response efforts in the community,” said study co-author Dr. Holger Schünemann, a professor at McMaster University in Hamilton, Ontario.”Governments and the public health community can use our results to give clear advice for community settings and health care workers on these protective measures to reduce infection risk,” Schünemann added.He and his colleagues found that keeping 3 feet or more apart from others was linked with a lower risk of infection, compared with less than 3 feet of distancing. The risk of infection by keeping a distance of 3 feet or more away from the infected individual was 3% versus 13% when the distance was less than 3 feet.

A State-By-State Guide To Reopening America Most of the decision-making regarding when and how businesses should reopen is left to the states. To help you quickly and easily find what you need to know, here’s a state-by-state guide to what types of businesses and gatherings are open and which are still closed, as of June 1.

 FDA pushes metformin recalls for 5 drugmakers after carcinogen contamination After the FDA identified a likely carcinogen in samples of the broadly used diabetes med metformin, recalls appeared likely. Now it’s official.The FDA said Thursday it had askedThe recall announcement comes just hours after the FDA declined to say whether it would pursue voluntary recalls after discovering NDMA contamination in tests metformin samples.  five metformin manufacturers to pull their extended-release metformin products, after pushing recalls of heartburn med Zantac and “sartan” blood pressure drugs for the same reason. A likely human carcinogen, N-Nitrosodimethylamine (NDMA), was discovered in samples of all three. The FDA said it was working with drugmakers to determine whether the recommended recalls would cause a shortage in the U.S. The move doesn’t apply to metformin’s immediate-release formulation, and the FDA specified that “there are additional manufacturers of the metformin ER formulation that supply a significant portion of the U.S. market, and their products are not being recalled.”


Hour 2 – Special Guest Brian Hooker PhD

Brian S. Hooker, PhD, PE, is an Associate Professor of Biology at Simpson University in Redding, California, where he specializes in chemistry and biology coursework. Additionally, Hooker is the Senior Process Consultant at ARES Corporation, working closely on process design for the environment restoration industry. His design efforts focus on industrial biotechnology and chemical engineering principles.

Brian dedicated over 15 years as a bioengineer and the team leader for the High Throughput Biology Team and Operations Manager of the DOE Genomics: Genomes to Life (GTL) Center for Molecular and Cellular Systems at the Pacific Northwest National Laboratory (PNNL). Dr. Hooker managed applied plant and fungal molecular biology research projects at the Pacific Northwest National Laboratory, where systems biology researchers are focused on understanding gene and protein networks involved in individual cell signaling, communication between cells in communities, and cellular metabolic pathways.

In 1985, Dr. Hooker earned his Bachelor of Science degree in chemical engineering, from California State Polytechnic University, Pomona, California. He earned his Masters of Science degree in 1988 and his doctorate in 1990, both in biochemical engineering, from Washington State University, in Pullman, Washington.

Brian Hooker has many accomplishments to his credit including: co-inventor for five patents, recipient of the Battelle Entrepreneurial Award in 2001, and a Federal Laboratory Consortium Recognition Award in 1999, for his work on “Reactive Transport in 3-Dimensions.” The breadth of Hooker’s 60 science and engineering papers have been published in internationally recognized, peer reviewed journals.

He has a teenage son with autism and has been active in the autism community since 2002.


New Research Study Clarifies Health Outcomes in Vaccinated versus Unvaccinated Children A new peer-reviewed study in the journal SAGE Open Medicine details the health outcomes of vaccinated versus unvaccinated children from three pediatric practices in the United States concludes that unvaccinated children have better health outcomes than their vaccinated peers.Children in the study were followed continuously for a minimum of 3 years from birth.  The study was based on medical records of over 2000 children enrolled in three pediatric practices and born between November 2005 and June 2015.  Vaccination status was determined based on any vaccination received prior to one year of age which yielded 30.9% of the children in the unvaccinated group. Results show that vaccination before one year of age led to significantly increased odds of medical diagnoses of developmental delays, asthma and ear infections in children.In a separate analysis, based on the number of vaccines received by one year of age, children receiving more vaccines were more likely to be diagnosed with gastrointestinal disorders compared to those who received no vaccines within the same timeframe.  In temporal analyses, children vaccinated prior to six months of age showed significant risks of each of the disorders studied as compared to unvaccinated children in the same timeframe.

One in Every 16 Irish Boys has Autism: Crisis Worse than COVID-19 and Nobody Cares According to National Health data released last week, autism incidence among Irish children is now at 4.3%, an 82% rise in five years. One in 16 boys is affected. US rates trail Ireland’s slightly only because CDC lies to minimize the crisis.In 2016, Judith Pinborough-Zimmerman, CDC’s Utah Principal Investigator for the Autism and Developmental Disabilities Monitoring Network (ADDM) filed a federal whistleblower lawsuit after reporting research fraud and intentional data manipulation by the CDC. The CDC routinely uses multiple strategies to hide the Autism Pandemic. “The autism explosion is an acute embarrassment to the CDC as they have totally failed to address environmental factors involved in causality.”The autism crisis dwarfs COVID-19. Bill Gates’ Institute for Health Metrics predicts 81,766 deaths from COVID. The average age of death is 75. In contrast, autism attacks infants presaging a lifetime of nightmarish agony. Half will never go on a date, write a poem, hit a baseball, join the military, pay taxes, cast a vote, run for office, speak, or use a toilet. Their cost of care is over 1/4 trillion U.S. dollars annually and rising.children receiving the Hep B vaccine in their first 30 days had an 1135% increased risk for an autism diagnosis.

COVID-19 Vaccines: Continuing the Long History of Medical Experimentation on Children May 22 was a banner day for the encroaching global vaccine police state, with three announcements from the UK signaling what we can surely also expect on this side of the Atlantic. First, the entities rushing to develop an experimental chimpanzee-derived COVID-19 injection—the conflict-of-interest-ridden Oxford Vaccine Group, Oxford’s Jenner Institute and pharmaceutical giant AstraZeneca—announced the imminent expansion of their clinical trials to a wider age range, including children aged 5 to 12 years, despite  “troubling results” when they administered the vaccine to rhesus monkeys. Endorsing the scale-up of the experiment to more than 30,000 eventual participants, including a trial to evaluate the vaccine in young children, the U.S. Department of Health and Human Services (HHS) immediately awarded a generous “$1.2 billion cash injection” for the UK effort (provided without any input from economically strapped American taxpayers). Then, to cap the day off, a UK Court of Appeal ominously ruled that local authorities can vaccinate children in foster care against their parents’ wishes, deploying the argument that “it is in the best interests of children to be immunised unless there is a specific reason for them not to be.”

Drugmakers struggle to meet demand for antidepressant Zoloft amid COVID-19 The COVID-19 pandemic has tested pharma’s supply chain and spawned several drug shortages. Now, with mental health suffering, antidepressant Zoloft and its generics are in short supply.A number of drugmakers are having trouble keeping up with higher demand, while some can’t get their hands on active pharmaceutical ingredients (APIs) to make the medicine, the FDA said Friday.Lupin, for one, is in “continuous production” but is citing higher demand and an API shortage for its supply shortfall. The company says its product will be on and off back order for a “few months.”Another generic drugmaker, Accord Healthcare, is “currently unable to obtain” the API to make the drug due to COVID-19, according to the FDA. Accord does have some lower doses available; its higher doses are expected to be in short supply for 60 days.Meanwhile, Aurobindo has “sufficient quantities available for current and future demand increases,” the FDA site says. Cipla’s InvaGen subsidiary has some Zoloft generics available, while some doses and bottle sizes are on backorder. Pfizer also cited higher demand for its supply constraints.Increased anxiety from COVID-19 lockdowns has contributed to the shortages, Bloomberg reports. Prescriptions for the drug grew 12% in March versus the same month last year, to 4.9 million, according to the news service. That was a record high; scripts fell to 4.5 million in April.



Remember Friends, The Power to Heal is Yours!


More upcoming RSB events:


You can help get the Robert Scott Bell Show carried on your local talk stations! Just call the station and request they carry the show. Ask them to contact GCN by calling 877-996-4327 ext. 123 and asking for “John” who manages the affiliate broadcast relationships. John can get any local AM or FM radio station connected with the global feed so that they can carry the show.

What would you like to hear from The Robert Scott Bell Show in 2020? Call us at 1-866-939-BELL (2355) and let your voice be heard!

Need it faster? Want to know as soon as content is added? Want the daily show notes? Click here to subscribe to The Robert Scott Bell Show content feed! 

Listen live here 3PM-5PM EST: Talk Stream Live

Previous episodes of the Robert Scott Bell Show: SoundCloud or Natural News Archive for the older shows.

You can now support The Robert Scott Bell Show by buying your supplements at the Natural News Store!

Aloe Vera Gel 3-Pack Special Includes FREE Youth-Derm® – thanks Stockton Aloe1, Inc.!PlusCBD_300x60_RSB15

How does 15% off on EVERY CBD PRODUCT SOUND? Right now for just RSB Show listeners. Click Here, or call CV Sciences at 855-758-7223 or 855-PLUS CBD. Use code RSB15 to get 15% off any products!

You can access the Tru-Align Body System at home by going to http://www.kacelia.com and entering RSB10 to get 10% off!

What keeps RSB and TMB strong through the stress of travel and colder winter months? Better Way Health Beta 1.3-D Glucan! Call them at 1-800-746-7640.

What’s the only kind of silver I take? Sovereign Silver. It’s now available in the Natural News StoreHave you tried the First Aid Gel yet? No more Neosporin.